[Clinical importance and pharmacodynamics of synthetic progesteroids].
D000152:Acne Vulgaris / Q000188:drug therapy; D000328:Adult; D000818:Animals; D002640:Chiari-Frommel Syndrome; D004715:Endometriosis / Q000188:drug therapy; D004717:Endometrium / Q000187:drug effects; D005003:Ethisterone / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D006628:Hirsutism / Q000188:drug therapy; D006801:Humans; D006913:Hydroxysteroid Dehydrogenases / Q000378:metabolism; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects; D007247:Infertility, Female / Q000188:drug therapy; D008234:Lynestrenol / Q000494:pharmacology / Q000627:therapeutic use; D008599:Menstruation Disturbances / Q000188:drug therapy; D008777:Methyltestosterone / Q000494:pharmacology / Q000627:therapeutic use; D009654:Norsteroids / Q000494:pharmacology; D010053:Ovary / Q000187:drug effects / Q000201:enzymology; D000292:Pelvic Inflammatory Disease / Q000188:drug therapy; D011085:Polycystic Ovary Syndrome; D011247:Pregnancy; D011372:Progestins / Q000494:pharmacology / Q000627:therapeutic use*; D051381:Rats; D014592:Uterine Hemorrhage / Q000188:drug therapy; D014621:Vagina / Q000187:drug effects
D009654:Norsteroids; D011372:Progestins; D006913:Hydroxysteroid Dehydrogenases; D008234:Lynestrenol; D005003:Ethisterone; D008777:Methyltestosterone
Beiträge zur klinischen Bedeutung und zum Wirkungsmechanismus der synthetischen Progesteroide.